Skip to content
Latest Updates
Delhi notifies Rules for online filing, tracking and appeals in time-bound delivery of citizen services Call for Papers | MNLU, Chhatrapati Sambhajinagar invites submissions for Volume V MNLU-CS Student Law Review Supreme Court to Establish Permanent Committee on Disability Rights; CJI Surya Kant Directs SCLSC to Set Up Panels of Lawyers and Sign Language Interpreters “Legislature cannot nullify a judgment by enacting law without removing the basis”: Andhra Pradesh High Court strikes down Section 147-A, Income-tax Act, 1961 as unconstitutional ICA and RICS to host Conclave on “Mediation in Transition: Institutional Trust, Professional Standards and the Age of Artificial Intelligence” Cyril Amarchand Mangaldas advises the Placement Agents on INR 3,500 crore QIP by Aegis Logistics Limited

Restraining order against 3 entities revoked, no adverse evidence in respect of violation of provisions of SEBI Act and PFUTP Regulations found

Content reader

Listen to this article

Ready to read this article aloud.

Securities and Exchange Board of India (SEBI): Madhabi Puri Buch, a Whole-Time Member addressed the issue of global depository receipts issued by Transgene Biotek Ltd. in order to defraud investors.

SEBI received a complaint against Transgene Biotek Ltd. alleging of fraud by issuing global depository receipts and misutilisation of proceeds by transferring the same for undisclosed and ulterior purposes under the garb of consideration for technology transfer to defraud the investors. SEBI conducted inquiry in order to find the probable impact of allegations on the securities market in India and on the interests of investors. SEBI passed an ad-interim ex-parte order which was later confirmed where based on the preliminary inquiry, six entities were restrained from accessing the securities market and trading in securities.

SEBI conducted a detailed inquiry in the entire GDR issued by Transgene Biotek Ltd. to ascertain the violation of securities laws. It found no adverse evidence or finding in respect of violation of provisions of SEBI Act and PFUTP Regulations against 3 entities with respect to their role in the scheme of diverting of the GDR proceeds of TBL and their endeavor to legitimatize the proceeds was found. Thus the confirmation order was liable to be revoked and the proceeding against the other entities ought to be continued. Therefore, under Section 19 of the SEBI Act read with Sections 11, 11(4) and 11-B of the SEBI Act confirmatory order was revoked. [Transgene Biotek Limited, In re,2018 SCC OnLine SEBI 167, order dated 06-11-2018]

.

WhatsApp LinkedIn

0 replies

Leave a Reply

Your email address will not be published. Required fields are marked *.

This site uses Akismet to reduce spam. Learn how your comment data is processed.